Why the study?
The study was conducted to explore the correlation between inflammatory indicators and blood lipids to provide a theoretical basis for the clinical diagnosis and treatment of polycystic ovary syndrome.
Are inflammatory markers correlated with blood lipids in patients with polycystic ovary syndrome?
Case-Control (n=236)
Are inflammatory markers correlated with blood lipids in patients with polycystic ovary syndrome?
Inflammatory markers are correlated with blood lipids in PCOS, suggesting a link between chronic low-grade inflammation and metabolic disturbances in these patients.
Answers are grounded in this paper and cite their sources.
Supports inflammation-metabolic link in PCOS; hypothesis-generating and requires prospective confirmation before clinical adoption.
OBJECTIVE: The purpose of this study was to explore the correlation between inflammatory indicators and blood lipids and to further provide a theoretical basis for the diagnosis and treatment of clinical polycystic ovary syndrome (PCOS). METHODS: Whole-blood cell counts and hormone and blood lipid levels were measured in 110 patients with PCOS and 126 healthy women. The differences in the above levels and the correlation between inflammation and blood lipid levels in the two groups were determined, and classified according to BMI. Differences in inflammatory indices were also analyzed. The independent risk factors for PCOS were analyzed by binary logistic regression. RESULTS: The PCOS group had greater BMI and greater body weight than the control group. The inflammatory indicators WBC, neutrophil, lymphocyte, monocyte counts and the NLR were significantly higher than those of the control group. It had higher testosterone (TSTO), triglyceride (TG) and total cholesterol (TC) levels. Correlation analysis showed that leukocyte and neutrophil counts were positively correlated with TSTO and TG levels and negatively correlated with HDL. In the BMI ≥ 24 and BMI < 24 groups, WBC was higher in PCOS patients than in healthy controls. Logistic regression showed that TSTO, TG and FSH were independent risk factors for PCOS. CONCLUSION: Inflammatory markers are correlated with blood lipids in PCOS. During the treatment of PCOS, blood lipids and serum inflammatory factors should be monitored.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2024) conducted a case-control in Polycystic ovary syndrome (PCOS) (n=236). Inflammatory indicators vs. Healthy women was evaluated on Correlation between inflammatory indicators and blood lipids.
Synapse has enriched 10 related papers. Consider them for comparative context: